ISPOR Quality Improvement in Cost Effectiveness Research Task Force



TASK FORCE CHAIR:
William McGhan, PharmD, PhD, Professor of Pharmacy and Health Policy, University of the Sciences, Philadelphia, PA, USA

TASK FORCE GROUP:
Maiwenn Al, PhD, Senior Research Fellow, institute for Medical Technology Assessment (iMTA), Erasmus MC, Rotterdam, Netherlands
Jalpa Doshi, PhD, Professor of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Isao Kamae, MD, DrPH, Professor of Applied Medical Statistics and Decision Sciences, Kobe University, Kobe, Japan
Steven E. Marx, PharmD, MS, Associate Director, Global Pharmaceutical Research & Development, Abbott Laboratories, Chicago, IL, USA
Donna Rindress, PhD, President & Managing Director, BioMedCom Consultants, Inc., Montreal, Quebec, Canada

BACKGROUND:
While the average health care researcher or practitioner may be able to follow major health care economic indicators and the release of major health care economic studies, a process to track overall quality of health care economic studies and their use in making health care policies is needed. Reviews and periodic quality reports advance international health care efficiency and quality and become a mainstay of our global effort to improve the economics and quality of life in all health care sectors.

Methods and statistics used in health care economic studies need to be critiqued periodically to improve the quality and usefulness for these studies and guidelines. It is also important to monitor the quality of health care economic study guidelines being used by journals, organizations and governments around the world for assessing new therapies and allocation of resources.

For more information, see: QUALITY IMPROVEMENT OF HEALTH CARE ECONOMIC EVALUATION RESEARCH AND USE IN HEALTH CARE POLICY

MISSION:
The mission of the ISPOR Quality Improvement in Cost Effectiveness Research (QICER) Task Force* and Its Use in Making Health Care Policy (through surveys, white papers, and sessions at ISPOR meetings) is to report and facilitate the improvement of health care economic evaluation research and its use in making health care policy.

The specific tasks are to:
  1. Develop periodic reports on the state and quality of health care economic evaluations and use of these studies in making health care policy
  2. Develop recognition of good health care economic evaluation research
  3. Develop a repository of ‘reference cases’ for health care economic evaluation research
  4. Develop a report card on the quality of journal guidelines on health care economic evaluations as well as government guidelines on health care economic evaluation information

*Health care economic evaluation research includes: budget impact analysis, cost-benefit analysis, cost-effectiveness analysis, cost-efficiency analysis, cost-consequence, cost-minimization analysis, cost-utility analysis, cost of illness, and cost of treatment studies


Task Forces Index

TF Members Access Only

  How to login

User name: first part of the email address (before @)
e.g. for jdoe@ispor.org it should be jdoe)
Password: ISPOR Member ID.

  Click here for login help

Contact ISPOR @ info@ispor.org  |  View Legal Disclaimer
©2008 International Society for Pharmacoeconomics and Outcomes Research.
All rights reserved under International and Pan-American Copyright Conventions.
 
Website design by Eagle Systems USA, Inc.